Andrograpanin, Isolated from Andrographis Paniculata, Exhibits Anti-Inflammatory Property in Lipopolysaccharide-Induced Macrophage Cells Through Down-Regulating the P38 MAPKs Signaling Pathways

Jun Liu,Zheng-Tao Wang,Bao-Xue Ge
DOI: https://doi.org/10.1016/j.intimp.2007.12.014
IF: 5.714
2008-01-01
International Immunopharmacology
Abstract:Andrographis paniculata Nees is an official herbal medicine for treatment of infection and inflammation in China. Andrograpanin, the one of diterpene lactones in A. paniculata, is a hydrolysate from neoandrographolide in vivo and in vitro. The goal of the present study was to investigate andrograpanin which effects on over production of nitric oxide (NO) and pro-inflammatory cytokines (TNF-alpha, IL-6 and IL-12p70) and the key signaling pathways involved in lipopolysaccharide (LPS)-activated macrophage cells. The results showed that NO and all three pro-inflammatory cytokines were inhibited by andrograpanin (15-90 microM) in a dose-dependent manner. The RT-PCR and western blotting assays showed that andrograpanin inhibited productions of NO and pro-inflammatory cytokines through down-regulating iNOS and pro-inflammatory cytokines gene expression levels. Further studies suggested that down-regulation of p38 mitogen-activated protein kinase (MAPKs) signaling pathways were involved in the anti-inflammatory activities of andrograpanin. This study provided evidences that andrograpanin might be useful as a potential anti-inflammatory leading compound for inflammatory drug development.
What problem does this paper attempt to address?